v3.26.1
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
 12 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments' Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value
The following tables summarize the Company’s financial instruments’ adjusted cost, gross unrealized gains and losses, and fair value by significant investment category as of June 30, 2026 (in thousands):

June 30, 2026
Adjusted CostGross Unrealized GainsGross Unrealized LossesFair ValueCash and Cash Equivalents (1)Short-Term Investments
Level 1
Money market funds$10,667 $— $— $10,667 $10,667 $— 
Subtotal$10,667 $— $— $10,667 $10,667 $— 
Level 2
Asset-backed securities11,832 — — 11,832 — 11,832 
Corporate bonds38,906 — (6)38,900 — 38,900 
US Government bonds37,886 2 — 37,888 — 37,888 
Subtotal$88,624 $2 $(6)$88,620 $— $88,620 
Total$99,291 $2 $(6)$99,287 $10,667 $88,620 
(1) Cash and cash equivalents on the Consolidated Balance Sheets includes securities that have a maturity of three months or less at the date of purchase. The carrying amount approximates fair value, primarily due to the short maturity of cash equivalent instruments.
Schedule of Amortized Costs and Fair Value of Investment Securities by Contractual Maturity
The following table represents the adjusted costs and fair value of cash equivalents and investments by contractual maturity as of June 30, 2026 (in thousands):
Available-For-Sale
Adjusted CostFair Value
Due within 1 year32,858 32,852 
Due after 1 year through 5 years66,433 66,435 
Total$99,291 $99,287